This study is currently not recruiting participants.

Bleb Needling with MMC after Ex-press Shunt - Intermediate Results of a Single Surgeon

Investigation of Bleb Needling Outcomes with Mitomycin C

Not Recruiting
100 years or below
All
Phase N/A

Brief description of study.

The purpose of this study is to look at outcomes of bleb needling with Mitomycin C with up to a 5-year follow-up period.

Detailed description of study

The purpose of this study is to look at outcomes of bleb needling with Mitomycin C with up to a 5-year follow-up period.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Healthy
  • Age: 100 years or below
  • Gender: All

This study investigates the outcomes of a procedure called bleb needling in patients who are administered Mitomycin C. Bleb needling is a technique used in eye surgeries, specifically to manage glaucoma by improving filtration and reducing intraocular pressure.

Participants in the study will undergo the bleb needling procedure with Mitomycin C. Mitomycin C is a type of medication that helps to prevent scarring. The study will observe how effective this procedure is over time.

  • Who can participate: Adults with glaucoma who require bleb needling.
  • Study details: Participants will receive the bleb needling procedure with Mitomycin C. The study will monitor the effects and outcomes of this procedure over a specified period.
  • Study Timelines: The study will last 5 years.
Updated on 19 Feb 2024. Study ID: 1211010090

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team